Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases (2017)
- Authors:
- Autor USP: TROSSINI, GUSTAVO HENRIQUE GOULART - FCF
- Unidade: FCF
- DOI: 10.1111/cbdd.13030
- Subjects: PLANEJAMENTO DE FÁRMACOS; DOENÇAS NEGLIGENCIADAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Chemical Biology and Drug Design
- ISSN: 1747-0277
- Volume/Número/Paginação/Ano: v. 90, n. 6. p. 1067-1078, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MELLO, Juliana da Fonseca Rezende e et al. Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases. Chemical Biology and Drug Design, v. 90, n. 6. p. 1067-1078, 2017Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13030. Acesso em: 06 maio 2024. -
APA
Mello, J. da F. R. e, Gomes, R. A., Fujii, D. G. V., Ferreira, G. M., & Trossini, G. H. G. (2017). Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases. Chemical Biology and Drug Design, 90( 6. p. 1067-1078). doi:10.1111/cbdd.13030 -
NLM
Mello J da FR e, Gomes RA, Fujii DGV, Ferreira GM, Trossini GHG. Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases [Internet]. Chemical Biology and Drug Design. 2017 ; 90( 6. p. 1067-1078):[citado 2024 maio 06 ] Available from: https://doi.org/10.1111/cbdd.13030 -
Vancouver
Mello J da FR e, Gomes RA, Fujii DGV, Ferreira GM, Trossini GHG. Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases [Internet]. Chemical Biology and Drug Design. 2017 ; 90( 6. p. 1067-1078):[citado 2024 maio 06 ] Available from: https://doi.org/10.1111/cbdd.13030 - Synthesis of inhibitors of sirtuin 2 for chagas disease
- Synthesis, molecular modeling and docking studies of nitrofurazone analogues as trypanomicine candidates
- Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides
- Building and validation of a pharmacophore model of LSD-1 inhibitors for virtual screening
- Quantitative structure-activity relationships (HQSAR, CoMFA and CoMSIA) studies for a COX-2 selective inhibitors
- Construction and validation of the CPB2.8 model and pharmacophore model design of cysteine proteases
- An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors
- Design and synthesis of sulfonylhydrazones derivatives as cruzain inhibitors
- Hologram QSAR studies of antiprotozoal activities of sesquiterpene lactones
- Resenha sem título próprio
Informações sobre o DOI: 10.1111/cbdd.13030 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
